GDF15 and cardiovascular disorder: Plasma levels of GDF15 have been studied as a biomarker in cardiovascular disease (Hochholzer et al, 2010) and elevated levels have been seen in metastatic CRC, breast and prostate carcinomas compared with normal controls (Welsh et al, 2003).